Systematic reviews and large volumes of patient testimony now show that stopping SSRIs and other antidepressants commonly causes symptoms that can be severe and long‑lasting, contradicting the decades‑old framing as a brief 'discontinuation syndrome'. Professional bodies and some policymakers are beginning to acknowledge this, prompting calls for better tapering protocols, informed‑consent practices, and surveillance.
— If accepted, this reframes prescribing norms, informed consent, and treatment guidelines — shifting responsibility onto clinicians and regulators and potentially changing millions of current and former patients' medical care.
2026.11.03
100% relevant
The editorial cites multiple systematic reviews, clinical studies, and aligns with thousands of online patient testimonies; one author is affiliated with the All‑Party Parliamentary Group for Prescribed Drug Dependence, showing emerging policy attention.
← Back to all ideas